Cells co-transfected with wild type PABPN1 and Pabpn1-targeting siRNA appeared to be partially rescued, suggesting that the previously reported knockdown and replace strategy would be viable in targeting OPMD-associated satellite cell pathology. The gene discussed is PABPN1; the disease is oculopharyngeal muscular dystrophy.